Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Nanoparticle-antagomiR based targeting of miR-31 to induce osterix and osteocalcin expression in mesenchymal stem cells

Nanoparticle-antagomiR based targeting of miR-31 to induce osterix and osteocalcin expression in mesenchymal stem cells

Thumbnail Image
Download
Name

journal.pone.0192562.pdf

Size

13.16 MB

Format

Adobe PDF

Checksum (MD5)

0294414a3b53c02aa6e20974957e0897

Download all files submitted through automated deposit
sword-2018-04-20.original.zip (12.7 MB)
Author(s)
McCully, Mark
•
V. Baptista, Pedro
•
Mullin, Margaret
•
Dalby, Matthew J.
•
Berry, Catherine C.
•
Osorio De Castro Conde, Joao
Date Issued
February 2018
Journal
PLOS ONE
Publisher
Public Library of Science
Citation
McCully, Mark et al. “Nanoparticle-antagomiR Based Targeting of miR-31 to Induce Osterix and Osteocalcin Expression in Mesenchymal Stem Cells.” Edited by Hélder A. Santos. PLOS ONE 13, 2 (February 2018): e0192562 © 2018 McCully et al
Version
Final published version
Abstract
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Mesenchymal stem cells are multipotent adult stem cells capable of generating bone, cartilage and fat, and are thus currently being exploited for regenerative medicine. When considering osteogenesis, developments have been made with regards to chemical induction (e.g. differentiation media) and physical induction (e.g. material stiffness, nanotopography), targeting established early transcription factors or regulators such as runx2 or bone morphogenic proteins and promoting increased numbers of cells committing to osteo-specific differentiation. Recent research highlighted the involvement of microRNAs in lineage commitment and terminal differentiation. Herein, gold nanoparticles that confer stability to short single stranded RNAs were used to deliver MiR-31 antagomiRs to both pre-osteoblastic cells and primary human MSCs in vitro. Results showed that blocking miR-31 led to an increase in osterix protein in both cell types at day 7, with an increase in osteocalcin at day 21, suggesting MSC osteogenesis. In addition, it was noted that antagomiR sequence direction was important, with the 5 prime reading direction proving more effective than the 3 prime. This study highlights the potential that miRNA antagomiR-Tagged nanoparticles offer as novel therapeutics in regenerative medicine.
MIT Department
Institute for Medical Engineering and Science
Harvard University--MIT Division of Health Sciences and Technology
Terms of Use
Creative Commons Attribution 4.0 International License
https://creativecommons.org/licenses/by/4.0/
Persistent DSpace Link
http://hdl.handle.net/1721.1/114944
DOI of Published Version
https://doi.org/10.1371/journal.pone.0192562
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.